Clinical Conditions Associated With Cardiovascular Disease
LabCorp offers tests that can help diagnose and identify the underlying causes of conditions frequently associated with the development of cardiovascular disease (CVD), such as dyslipidemia, atherosclerosis, and familial hypercholesterolemia.
|
Test Name |
Test N° |
Comments |
|---|---|---|
|
*National Heart, Lung, and Blood Institute. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Executive Summary. Bethesda, Md: National Heart, Lung, and Blood Institute, National Institutes of Health; 2001. NIH Publication 01-3670. |
||
|
Dyslipidemia |
||
|
Lipid Cascade |
Reflexes to lipoprotein analysis by nuclear magnetic resonance (NMR) when LDL-C is <130 mg/dL. |
|
|
Lipid Panel plus |
Order Apolipoprotein B or NMR LipoProfile® indicated in addition to Lipid Panel. |
|
|
Apolipoprotein B or |
||
|
NMR LipoProfile® Without Lipids (Without Graph) |
||
|
Secondary Dyslipidemia (Rule out common causes: diabetes, hypothyroidism, liver disease, renal disease*) |
||
|
Alanine Aminotransferase (ALT/SGPT) |
Drugs such as progestins, anabolic steroids, and corticosteroids increase LDL cholesterol and decrease HDL cholesterol and are also causes of secondary dyslipidemia.* |
|
|
Aspartate Aminotransferase (AST/SGOT) |
||
|
Glomerular Filtration Rate, Estimated (eGFR) |
||
|
Glucose, Plasma |
||
|
Hemoglobin (Hb) A1c |
||
|
Microalbumin:Creatinine Ratio, Random Urine |
||
|
Renal Function Panel |
||
|
Thyroid-stimulating Hormone (TSH) |
||
|
Atherosclerosis / Inflammation |
||
|
C-Reactive Protein (CRP), High Sensitivity (Cardiac Risk Assessment) |
||
|
Fibrinogen Activity |
||
|
Fibrinogen Antigen |
||
|
Homocyst(e)ine, Plasma |
||
|
Lipoprotein (a) |
||
|
Plasminogen Activator Inhibitor (PAI-1) Activity |
||
|
Sedimentation Rate, Modified Westergen |
||